GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medigene AG (XTER:MDG1) » Definitions » Price-to-Operating-Cash-Flow

Medigene AG (XTER:MDG1) Price-to-Operating-Cash-Flow : (As of Dec. 15, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Medigene AG Price-to-Operating-Cash-Flow?

As of today (2024-12-15), Medigene AG's share price is €1.144. Medigene AG's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2024 was €-1.10. Hence, Medigene AG's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Medigene AG's Price-to-Operating-Cash-Flow or its related term are showing as below:

During the past 13 years, Medigene AG's highest Price-to-Operating-Cash-Flow Ratio was 4.66. The lowest was 2.92. And the median was 3.73.

XTER:MDG1's Price-to-Operating-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 25.685
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Medigene AG's Cash Flow from Operations per share for the six months ended in Jun. 2024 was €-0.55. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2024 was €-1.10.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 15.20% per year.

During the past 13 years, Medigene AG's highest 3-Year average Operating Cash Flow per Share Growth Rate was 47.10% per year. The lowest was -131.60% per year. And the median was 1.30% per year.


Medigene AG Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Medigene AG's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medigene AG Price-to-Operating-Cash-Flow Chart

Medigene AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 4.14 -

Medigene AG Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 4.14 - - -

Competitive Comparison of Medigene AG's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Medigene AG's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medigene AG's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medigene AG's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Medigene AG's Price-to-Operating-Cash-Flow falls into.



Medigene AG Price-to-Operating-Cash-Flow Calculation

Medigene AG's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=1.144/-1.096
=

Medigene AG's Share Price of today is €1.144.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medigene AG's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2024 was €-1.10.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Medigene AG Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Medigene AG's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Medigene AG Business Description

Industry
Traded in Other Exchanges
Address
Lochhamer Strasse 11, Martinsried, Planegg, BY, DEU, 82152
Medigene AG is an immuno-oncology biotechnology company. focused on developing differentiated T Cell Receptor engineered T cell (TCR-T) therapies for the treatment of multiple solid tumor indications with a high unmet medical need. The operating segments of the organization are Immunotherapies and Other products. Immunotherapies consist of T-cell receptor-based adoptive T-cell therapy and DC vaccines. The group operates in the United States, Germany, and Asia, of which the majority of the revenue is derived from operations in Germany.

Medigene AG Headlines

No Headlines